Search
for
Sort by
Research 691–720 of 1000+
- Lichen Planopilaris: The first biopsy layer microbiota inspection
- The Relationship Between Mental Health and Drugs used in Dermatology
- Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Dermatological Manifestations of COVID-19: A Comprehensive Review
- Cutaneous epitheliotropic T‐cell lymphoma in a sugar glider (<i>Petaurus breviceps</i>)
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- AUTOIMMUNE CICATRICIAL ALOPECIA AND THE ROLE OF TRICHOSCOPY IN ITS DIAGNOSIS: A LITERATURE REVIEW
- The Rotterdam Study: objectives and design update
- Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
- Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus
- Clinical response and time to improvement with 308-nm excimer laser therapy in scarring alopecia: a retrospective cohort study
- IL-15 in T-Cell Responses and Immunopathogenesis
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- Beyond the Surface: Understanding Demodex and Its Link to Blepharitis and Facial Dermatoses
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- A review of environmental and health effects of synthetic cosmetics
- 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (TSG) from Polygonum multiflorum Thunb.: A Systematic Review on Anti-Aging
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Conference 2022, The Sequel
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Metabolic syndrome — a new definition and management guidelines
- More is not always better in hair growth factors. epidermal growth factor: hair growth factor involved in alopecia areata pathogenesis
- Chitosan Nanoparticle-Encapsulated Cordyceps militaris Grown on Germinated Rhynchosia nulubilis Reduces Type II Alveolar Epithelial Cell Apoptosis in PM2.5-Induced Lung Injury
- A Case of Hidradenitis Suppurativa Responsive to Testosterone Replacement Therapy
- Cytokine Engineering Approaches for Regenerative Medicine
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata